Clin2
NCT02646475Possibly a fitRecruiting

Study angiotensin medicine to improve metabolism in obesity

ObesityInsulin ResistanceHypertensionMetabolic Cardiovascular Syndrome

Treatments studied

Part of Heart & circulation, Hormones & metabolism clinical trials.

This Phase 1 study tests how a medication that affects the body’s angiotensin system (angiotensin-(1-7)) changes metabolism in adults with obesity, insulin resistance, and high blood pressure. It may help researchers understand whether this approach can improve blood sugar/insulin function and related body changes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
26 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • Age 18 to 60 years old
  • Body mass index (BMI) between 30 and 40 (obesity, not “morbid obesity” over 40)
  • Have insulin resistance (a lab measure called HOMA2-IR higher than 2.2)
  • Have high blood pressure (repeated readings above 130/85 or you take blood pressure medicine)
  • Cannot be pregnant or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05312892Recruiting· Phase 1/Phase 2
Study for weight-related hormone signals in people with high blood pressure

This early-phase study looks at how the body’s “fight-or-flight” signals may be involved in weight gain (obesity) and high blood pressure. It may help researchers understand the biology and guide future treatments.

Nashville, Tennessee
NCT06482853Recruiting· Early Phase 1
Heart effects of a natural protein in obesity and high blood pressure

This study tests whether a natural protein called angiotensin-(1-7) can improve heart health in people with obesity and high blood pressure. It may help researchers find new ways to treat these conditions together.

Hershey, Pennsylvania
NCT04934228Recruiting· Phase 1
Study targeting inflammation in people with obesity and high blood pressure

This Phase 1 study looks at a treatment aimed at reducing “inflammation patterns” that are common in obesity and insulin resistance. If you meet specific health and lab criteria, you may be asked to visit a research lab and provide blood samples to see how the treatment affects your body.

Kansas City, Kansas
NCT06065930Recruiting
Adaptive Mechanisms in Grown-Up Obesity (AMIGROS)

This study looks at how the body adapts in people with different body weights and insulin sensitivity. It compares lean adults and those with obesity, with or without insulin resistance, to understand metabolism better. Participation involves a few visits and some tests.

Gothenburg, Region Vastra Gotaland
NCT06286761Recruiting
Validation of lab tests for metabolism research

This study checks how reliable routine lab tests and research techniques are for metabolism research. It may help you if you are a healthy adult with a stable weight and no major health conditions.

Columbia, Missouri
NCT07294794Not yet recruiting
Personalised blood pressure medicine based on your body chemistry

This trial tests whether a simple metabolic test (using your blood or urine) can help your doctor personalise which blood pressure medicine is best for you. The goal is to improve blood pressure control with fewer side effects.

Hamburg

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.